Histone H2A variant H2AX is a dose-dependent suppressor of oncogenic chromosome translocations. H2AX participates in DNA double-strand break repair, but its role in other DNA repair pathways is not known. In this study, role of H2AX in cellular response to alkylation DNA damage was investigated. Cellular sensitivity to two monofunctional alkylating agents (methyl methane sulfonate and N-methyl-N 0 -nitro-N-nitrosoguanidine (MNNG)) was dependent on H2AX dosage, and H2AX null cells were more sensitive than heterozygous cells. In contrast to wild-type cells, H2AX-deficient cells displayed extensive apoptotic death due to a lack of cell-cycle arrest at G 2 /M phase. Lack of G 2 /M checkpoint in H2AX null cells correlated well with increased mitotic irregularities involving anaphase bridges and gross chromosomal instability. Observation of elevated poly(ADP) ribose polymerase 1 (PARP-1) cleavage suggests that MNNG-induced apoptosis occurs by PARP-1-dependent manner in H2AX-deficient cells. Consistent with this, increased activities of PARP and poly(ADP) ribose (PAR) polymer synthesis were detected in both H2AX heterozygous and null cells. Further, we demonstrate that the increased PAR synthesis and apoptotic death induced by MNNG in H2AX-deficient cells are due to impaired activation of mitogen-activated protein kinase pathway. Collectively, our novel study demonstrates that H2AX, similar to PARP-1, confers cellular protection against alkylation-induced DNA damage. Therefore, targeting either PARP-1 or histone H2AX may provide an effective way of maximizing the chemotherapeutic value of alkylating agents for cancer treatment.
Introduction
H2AX, a variant form of histone H2A, is rapidly phosphorylated at serine 139 in response to DNA double-strand breaks (DSB) originating from exogenous DNA damage (Rogakou et al., 1998 (Rogakou et al., , 1999 replication fork collision (Ward and Chen, 2001; Furuta et al., 2003) , shortened telomeres (Takai et al., 2003; d'Adda di Fagagna et al., 2003) , apoptosis (Rogakou et al., 2000) and transcription inhibition (Mischo et al., 2005) . Phosphorylated histone H2AX, designated as g-H2AX, forms distinct nuclear foci at or in the vicinity of DSB sites (Rogakou et al., 1999) . g-H2AX foci colocalize with many DNA damage-signaling components, including ataxia telangiectasia-mutated (ATM), BRCA1, 53BP1, MDC1, Rad51 and Mre11/Nbs1/ Rad50 complex (Fernandez-Capetillo et al., 2004) . g-H2AX is important for recruitment and retention of DSB repair factors Celeste et al., 2003b) such as Nbs1 (Nijmegen breakage syndrome gene product) and 53BP1 (53 binding protein 1) during the late hours after ionizing radiation (IR). H2AX phosphorylation in response to DSB is mediated by three kinases (Wang et al., 2005) belonging to a super family of phosphatidylinositol kinase-like kinases. These include ATM, ATM-and Rad3-related (ATR) and DNA-dependent protein kinase (DNA-PK). Although ATM and DNA-PK are involved in H2AX phosphorylation in an overlapping manner after IR-induced DSB (Stiff et al., 2004) , H2AX phosphorylation is mainly mediated by ATR after replicative stress (Ward and Chen, 2001) .
Two evolutionarily conserved pathways, nonhomologous end joining (NHEJ) and homologous recombination (HR), are involved in the repair of DSB in eukaryotes. Although g-H2AX is dispensable for DSB recognition (Celeste et al., 2003b) , available data indicate its importance in the modulation of both NHEJ and HR pathways. Elimination of the serine residue at 129 of H2A at the C-terminal region led to NHEJ impairment in yeast (Downs et al., 2000) . Also, importance of ser129 of H2A in DNA replicationmediated DSB repair has been demonstrated in Saccharomyces cerevisiae . Mice deficient in H2AX are characterized by male-specific infertility, growth retardation and diminished levels of immunoglobulin isotypes (Bassing et al., 2002; Celeste et al., 2002) . All these pleiotropic phenotypes have been found associated with enhanced chromosomal instability. Both embryonic stem (ES) and mouse embryonic fibroblasts (MEF) deficient in H2AX showed elevation of spontaneous and IR-induced chromosomal aberrations (Bassing et al., 2002; Celeste et al., 2002) . Spectral karyotypic analysis revealed abnormally high levels of random translocations and complex rearrangements in as many as 24-43% of the metaphases in H2AX null cells as compared to 3-5% in wild-type cells . Although the fidelity of V(D)J recombination is apparently normal in H2AX-deficient cells, enhanced chromosomal instability indicates that H2AX is required for DNA repair and genomic integrity. Consistent with the genomic instability features, H2AX deficiency has been demonstrated to modify the tumor susceptibility in mice (Bassing et al., 2003; Celeste et al., 2003a) .
H2AX is a critical factor for DNA DSB repair, but its involvement in other DNA repair pathways is not clearly established. In this study, we have evaluated the role of H2AX for the first time in the repair of DNA damage induced by monofunctional alkylating agents. Alkylating agents are mutagenic and genotoxic, and can form adducts with RNA and protein that are likely to contribute to the cytotoxicity (Hurley, 2002) . All the major DNA repair mechanisms (base excision repair (BER), nucleotide excision repair, mismatch repair and recombination repair) are involved in the processing of alkylating agent-induced DNA damage (Hoeijmakers, 2001) . Any deficiency in these DNA repair pathways can lead to stable mutations leading to cancer, developmental abnormalities and premature aging. Our novel study suggests that H2AX, similar to poly(ADP) ribose polymerase 1 (PARP-1), confers cellular protection against alkylation DNA damage. Further, our study indicates that H2AX is important for cell survival through optimal activation of mitogen-activated protein kinase (MAPK) pathway in response to alkylation DNA damage.
Results
H2AX null cells are extremely sensitive to monofunctional alkylating agents Data obtained on clonogenic survival after IR treatment in H2AX-proficient and -deficient ES cells were in accordance with a previously published report (Bassing et al., 2002) . To evaluate the role of H2AX in repair pathways other than DSB, clonogenic survival assay was performed after treatment with alkylating agents (methyl methane sulfonate (MMS) and N-methyl-N 0 -nitro-N-nitrosoguanidine (MNNG). H2AX-deficient cells showed increased sensitivity to both of these agents. The LC50 value (that reduces the cell survival by 50%) for MMS and MNNG was found to be 0.25 mM and 1.25 mM, respectively for H2AX null cells as compared to 1 mM and 3.1 mM for H2AX-proficient cells. In addition, cell proliferation determined using the CyQuant assay ( Figure 1d ) revealed a reduction in proliferation by 18.5 and 21.9% after treatment of wildtype cells with 5 and 10 mM of MNNG, respectively. In contrast, proliferation was greatly reduced by MNNG at both concentrations in H2AX null cells (49.7% for 5 mM and 66.4% for 10 mM). H2AX heterozygous cells showed an intermediate response in proliferation after 5 mM (35.1%) and 10 mM (46.4%) of MNNG treatment.
Lack of G 2 /M arrest after alkylation DNA damage in H2AX null cells To verify whether or not the increased sensitivity of H2AX-deficient cells to alkylating agents is due to the lack of G 2 /M arrest, cell-cycle analysis was performed in cells of all the three genotypes 48 h after MNNG treatment. Although a modest increase in the proportion of G 2 /M cells was observed in both H2AX-proficient and heterozygous cells, H2AX null cells failed to show an efficient G 2 /M checkpoint after treatment with a high concentration of MNNG. Consistent with the lack of G 2 /M arrest, proportion of sub-G 1 cell population resulting from apoptosis was greatly increased as a function of MNNG dose in H2AX null cells (Figure 2a ). This observation was verified by apo-bromodeoxyuridine (BrdU) transferase-mediated dUTP nick endlabeling (TUNEL) assay (Invitrogen, Carlsbad, CA, USA; Figure 2b ). Cells labeled by TUNEL assay were analysed by flow cytometry. The frequency of apoptotic cells detected by flow cytometry as sub-G 1 population was highly similar to that detected by Apo-BrdU TUNEL assay. A representative apoptotic cell characterized by typical fragmented chromatin bodies is shown in Figure 2c .
H2AX null cells show mitotic catastrophe after alkylation damage Observations of the lack of G 2 /M checkpoint and increased apoptosis in H2AX null cells after MNNG treatment prompted us to investigate the extent of genomic instability in these cells. For this purpose, anaphase bridges and chromosomal aberrations, which are the characteristic features of mitotic catastrophe, were monitored. Consistent with the lack of G 2 /M arrest, increased level of anaphase bridges (48%) was observed 24 h after 5 mM MNNG treatment in H2AX null cells. Further, a large fraction of anaphase and telophase cells showed chromosome fragments that were excluded from the spindle (Figure 3 ). To determine whether the chromosomal instability is responsible for increased cellular sensitivity, chromosomal aberrations were analysed in H2AX-proficient and -deficient cells. As alkylating agents induce complex exchange-type aberrations, telomere labeling was performed to score the aberrations. Telomere labeling enabled us to identify the orientation of chromosomes in complex exchanges (Figure 4a ). The percentages of aberrant metaphases in wild-type cells were found to be 28, 24 and 40%, respectively for 1, 2 and 4 mM of MNNG treatment. In contrast to wild-type cells, 61.5, 68 and 87.5% of the metaphases were found to be aberrant in H2AX null cells after treatment with 1, 2 and 4 mM MNNG. The frequency of different types of aberrations as well as the total number of aberrations per cell is shown in Figure 4b . The extensive chromosomal instability observed in H2AX null cells after MNNG treatment indicates that H2AX is critical for the maintenance of chromosomal stability after alkylation exposure. In addition, H2AX-deficient cells also showed the lack of 53BP1foci formation after treatment with MNNG (see supplemental data 1; Figure 1 ).
Alkylation DNA damage triggers PARP-1-mediated apoptosis in H2AX-deficient cells PARP is an abundant nuclear protein with demonstrated roles in diverse DNA metabolic activities. It is well established that PARP-1 is cleaved in apoptotic cells through the concerted action of caspases 3 and 7 (Soldani and Scovassi, 2002; Bouchard et al., 2003) in response to many DNA-damaging agents including MNNG. Therefore, we wished to determine whether the MNNG-induced apoptosis in H2AX-deficient cells occurs via PARP-1 cleavage. Western blot analysis revealed an elevation in the cleaved fragments of PARP-1 (89 and 29 kDa) with increasing concentrations of MNNG in both H2AX heterozygous and null cells analysed 3 h after MNNG treatment ( Figure 5a ). Similar results were also obtained 24 h after MNNG treatment. In addition to 89 kDa fragment, a B50 kDa fragment was also detected in all the three cell lines that remained unaltered by MNNG treatment. As PARP-1 is cleaved by caspases 3 and 7, relative levels of full-length and cleaved caspases 3 and 7 were subsequently examined in cells of all the three genotypes treated with 10 and 20 mM MNNG ( Figure 5b ). Consistent with elevated PARP-1 cleavage, increased level of cleaved caspases was observed in both H2AX heterozygous and null cells 24 h after MNNG treatment. These results clearly demonstrate that MNNG-induced apoptosis occurs by PARP-1-mediated pathway in H2AX-deficient cells. In contrast to caspases 3 and 7, caspase 9, which is dispensable for PARP-1-mediated apoptosis, remained essentially unaltered in both sham-and MNNG-treated cells of all the three genotypes ( Figure 5b ).
H2AX-deficient cells show increased PARP-1 activity and PAR synthesis
In response to DNA damage, PARP-1 is activated and catalyses the synthesis of poly(ADP) ribose (PAR) polymers that are covalently attached to a number of acceptor proteins. The main protein among them is PARP-1 itself. To determine whether PARP activity is altered in H2AX-deficient cells after MMNG damage, PARP activity was determined in the whole-cell extracts prepared from sham-and MNNG-treated cells. PARP activity assay was performed essentially according to the manufacturer's protocol (R&D Systems, Minneapolis, MN, USA). Even in the absence of exogenous damage, PARP activity was higher both in H2AX heterozygous and null cells in comparison to H2AX-proficient cells. Although, PARP activity measured after 3 and 24 h of MNNG treatment showed a gradual decline in all the three genotypes, PARP activity in H2AX-deficient cells was higher than that of H2AX-proficient cells ( Figure 6a ). As PARP-1 is responsible for bulk of PARP activity, we wished to determine whether the increased PARP activity observed in unchallenged H2AX heterozygous and null cells is due to increased PARP-1 expression. For this purpose, PARP-1 expression was monitored both at the mRNA and protein levels. Consistent with increased PARP activity, PARP-1 expression detected by reverse transcription (RT)-PCR and western blot analyses was higher in both heterozygous and homozygous cells deficient in H2AX (Figure 6b) . These data clearly demonstrate a close correlation between increased PARP activity and increased PARP-1 expression in H2AX-deficient cells. It is unclear at this point whether elevated PARP-1 level is due to increased stability of PARP-1 mRNA and protein in H2AX-deficient cells. We next examined whether or not PAR synthesis is also increased in H2AX-deficient cells with and without MNNG treatment. Western blot analysis was performed using a PAR antibody (mouse monoclonal immunoglobulin G; Trevigen, Gaithersburg, MD, USA). In corroboration with increased PARP activity, increased levels of PAR synthesis were detected in both H2AX heterozygous-and homozygous-deficient cells either with or without MNNG treatment (see supplemental data 1, Figure 2) .
MNNG impairs the activation of MAPK signaling pathway in H2AX-deficient cells
A recent study has shown that the massive PAR synthesis induced by MNNG treatment leads to apoptotic death through downregulation of phosphorylated extracellular signal-related kinase (ERK1 and ERK2) proteins, which are members of MAPK signal transduction pathway (Ethier et al., 2007) . In the light of this observation, it is important to determine whether or not similar effect of PAR synthesis on MAPK pathway is observed in H2AX-deficient cells. To address this issue, western blot analysis was performed using the total cellular proteins isolated from sham-and MNNGtreated H2AX-proficient and -deficient cells at 3 and 24 h postrecovery times. H2AX-proficient cells did not show any alteration in the relative levels of ERK1 and ERK2 phosphorylation either with or without MNNG treatment, In contrast, phosphorylation levels of both ERK1 and ERK2 proteins were greatly reduced with increasing MNNG concentrations in both heterozygous and null cells at both recovery times (Figure 7) . However, the total cellular levels of unmodified ERK1 and ERK2 proteins did not show much alteration in all the three cell lines. This observation illustrates that H2AX is critical for the optimal activation and persistence of MAPK pathway after alkylation DNA damage. Interestingly, a clear H2AX dose-dependent effect was also observed in the phosphorylated ERK1 and ERK2 proteins even in undamaged cells. Collectively, our novel study highlights the importance of H2AX in the regulation of MAPK signal transduction pathway. Elucidation of the precise molecular link between MAPK and H2AX awaits further investigations.
Discussion
H2AX is rapidly phosphorylated at serine 139 in response to DSB generated by IR (Rogakou et al., 1998 (Rogakou et al., , 1999 and stalled replication forks (Ward and Chen, 2001; Furuta et al., 2003) . H2AX is an essential DSB repair factor, but its role in other DNA repair pathways is largely unknown. This study provides the novel evidence for the critical importance of H2AX in cellular protection against alkylation DNA damage.
DNA alkylating agents are widely used in cancer therapy and mismatch repair-deficient cancer cells show resistance to cisplatin and alkylating agents such as MNNG (Aebi et al., 1997; Karran et al., 2003) . Therefore, identification of key genetic factors responsible for cellular defense against alkylation damage is critical for improving the efficiency of cancer treatment. A previous study has shown that 95 and 79% of total DNA methylation is generated by MMS and MNNG, respectively (Beranek, 1990 ) and these modified bases (N7-methylguanine, N3-methyladenine and N3-methylguanine) are removed by BER pathway (Mitra and Kaina, 1993) . Analogous to H2AX-deficient cells, DNA polymerase b (an important BER factor)-deficient cells show increased apoptosis and chromosome breakage upon exposure to alkylating agents (Ochs et al., 1999; Horton et al., 2005) . Similarities observed in terms of alkylation DNA damage-induced cell killing and chromosomal aberrations between DNA polymerase b and H2AX-deficient cells strongly suggest that H2AX cells may be deficient in BER activity.
Our study has unraveled an interesting molecular link between H2AX and PARP-1 in response to alkylation DNA damage. In contrast to wild-type cells, H2AX-deficient cells show increased PARP activity and PAR synthesis even in the absence of exogenous DNA damage. Further, apoptosis induced by MNNG occurs in a PARP-1-mediated manner in H2AX-deficient cells. Elevated PARP activity and PAR synthesis observed in H2AX-deficient cells suggest a role for H2AX in the regulation of PARP activity. The deregulation of PARP activity may be responsible for the abnormal cellular response of H2AX-deficient cells to MMS and MNNG. In the present study, increased level of ribosylated PARP-1 detected both in H2AX heterozygous and null cells for an extended period of time (24 h after treatment) indicates that H2AX is important for maintaining the balance between PARP and PARG system after alkylation DNA damage. The extreme sensitivity of both PARP-1-and H2AX-deficient cells to MMS and MMNG strongly indicate the critical requirement of both of these gene products for cellular defense against alkylating agents.
Requirement for H2AX in G 2 /M arrest after low doses of low LET radiation (0.5-2.5 Gy) was demonstrated earlier . Similarly, requirement of ATM kinase for low-dose radiation-induced G 2 /M checkpoint was also reported (Xu et al., 2002) . In this study, lack of G 2 /M arrest was demonstrated in H2AX-deficient cells after treatment with a high dose of MNNG (20 mM). A recent paper has shown that MNNG activates cell-cycle checkpoints in a dose-dependent manner (Beardsley et al., 2005) and Chk2 was found to be dispensable for the checkpoint induced by 25 mM MNNG. Although both IR and MNNG induce DSB, their mode of induction is distinctly different. IR directly induces DSB, whereas DSB generated by MNNG are due to simultaneous processing of clustered AP (apurinic/apyrimidinic) sites on opposite DNA strands (Lomax et al., 2004) . Further, MNNG induces DSB only in S-phase cells and the DSB abundance after MNNG treatment may depend on the initial lesion load. Due to differences in the mode of DSB induction by IR and MNNG, it is logical to assume that the yield of DSB may considerably differ between the two treatment conditions. Beardsley et al. DNA damage in H2AX-deficient cells are suggestive of premature progression of damaged cells from G 2 to mitosis. These results also highlight the importance of H2AX in the maintenance of proper chromosome segregation and stability. Our finding together with the recent demonstration of g-H2AX enriched in mitotic cells (Ichijima et al., 2005; McManus and Hendzel, 2005) indicate that H2AX is important for mitotic cell integrity. Collectively, this study reveals that in addition to being a regulatory factor for PARP-1 activation, H2AX also participates in maintaining the chromosomal stability through regulation of G 2 /M checkpoint control.
MAPK family members, that include ERK1 and ERK2, c-Jun N-terminal kinase and p38, have been shown to be activated by different types of external stimuli (Tibbles and Woodgett, 1999) . Requirement for ERK1 and ERK2 activation has been demonstrated for DNA damage-induced G 2 /M arrest in mammalian cells (Chou et al., 2007; Yan et al., 2007) . In this study, we demonstrated that the lack of activation and persistence of phosphorylated ERK1 and ERK2 proteins after alkylation damage correlate with lack of G 2 /M arrest in H2AX-deficient cells. A recent study has demonstrated the correlation between PAR synthesis and ERK1/ ERK2 activation after treatment with a high concentration of MNNG (100 mM) in HeLa cells (Ethier et al., 2007) . Inhibition of PAR synthesis by PARP-1 inhibitor prevents the loss of phosphorylation of ERK1/ERK2 and confers cellular protection against MNNG treatment. Also, inhibition of ERK1/ERK2 phosphorylation by UO126 resulted in the elevation of MNNG-induced apoptotic death in HeLa cells. A few recent studies have unraveled the molecular interplay between PARP-1 and ERK1/ERK2 and the activation of PARP-1 and ERK1/ ERK2 seems to be interdependent (Kauppinen et al., 2006; Cohen-Armon et al., 2007) . In the present study, we observed the lack of activation and persistence of ERK1/ERK2 phosphorylation even at low concentrations of MNNG in H2AX-deficient cells. Interestingly, phosphorylation level of ERK1/ERK2 proteins was also found reduced in H2AX heterozygous and null cells in the absence of MNNG treatment. This observation clearly points out that H2AX is required for the optimal activation of MAPK pathway. Future studies are required to understand the mechanism for the regulation of MAPK pathway by H2AX.
Observation of H2AX dose-dependent cytotoxic effects of alkylating agents in heterozygous and homozygous cells indicates that PARP-1 activity is deregulated by the absence of H2AX. This study provides evidence that H2AX is a critical factor for cellular protection against alkylating agents through regulation of PARP-1 activity. The intrinsic molecular interplay between PARP-1 and H2AX may be important for the coordinated regulation of signal transduction, cell-cycle and DNA repair activities in response to alkylation DNA damage. Owing to their importance in cellular protection against alkylation damage, targeting either PARP-1 or histone H2AX may provide an effective way of maximizing the chemotherapeutic value of alkylating agents for cancer treatment.
Materials and methods

Cell lines and culture conditions
Mouse ES cells differing in the functional status of H2AX (wild type ( þ / þ ), heterozygous ( þ /À) and null (À/À)) were generously provided by Dr CH Bassing and Dr FW Alt (Department of Genetics, The CBR Institute for Biomedical Research, The Children's Hospital, Harvard Medical School, Boston, MA, USA). Procedures followed for the generation and propagation of these cells lines have been described by Bassing et al. (2002) . Cells were routinely cultured in knockout DMEM (Invitrogen) supplemented with 10% ES-tested fetal bovine serum. Other components of the medium for ES cell culture were essentially the same as described by Bassing et al. (2002) .
Treatment of ES cells, clonogenic survival assay and immunofluorescence analysis
To determine the sensitivity of H2AX-proficient and -deficient (heterozygous and homozygous) cells to alkylating agents, clonogenic survival experiments were performed. For survival experiment, 1 Â 10 3 cells from wild-type H2AX, heterozygous and null cell lines were seeded in 0.1% gelatin-coated 6 cm dishes 18 h prior to treatment. For alkylation damage, cells were treated with indicated concentrations of MMS and MNNG for 3 h. Cells were washed once in complete medium and incubated in drug-free medium for 7-10 days and colonies were fixed in 70% ethanol and stained with Coomassie brilliant blue (0.5%). For comparison, survival experiment with different doses of g-rays (0.5, 1, 2 and 4 Gy) was performed (Gamma Cell 40; Atomic Energy of Canada, Chalkriver, Ontario, Canada). At least three independent determinations were made for each treatment condition. Immunofluorescence staining of 53BP1 (Novus Biologicals, Littleton, CO, USA) was performed essentially as described before Geard, 2001, 2004) .
Cell-cycle analysis
For cell-cycle analysis, H2AX wild-type, heterozygous and null cells were seeded at a density of 500 000 cells in 10 cm culture dishes 18 h prior to treatment. Cells were treated with MNNG for 90 min at 37 1C. Cells after different postincubation times (24 and 48 h) were trypsinized, washed once in phosphate-buffered saline (PBS) and fixed in 70% ethanol. Samples were analysed using a Becton Dickinson (Franklin Lakes, NJ, USA) FACSCalibur and at least 10 000 events were recorded for each sample.
Effect of MNNG on Cell proliferation by CyQuant assay
Cells from all the three genetic backgrounds were seeded into 96-wells plate at a density of 7500 cells per well in 200 ml of Detection of apoptosis by Apo-BrdU TUNEL assay For the determination of apoptotic cells, an apo-BrdU TUNEL assay (Invitrogen) was performed. Cells were trypsinized and DNA break sites were labeled by Apo-BrdU kit following the manufacturer's protocol (Molecular Probes, Carlsbad, CA, USA). Cells labeled with fluorescein were analysed by FACSCalibur and FACScan software (Becton Dickinson, Franklin Lakes, NJ, USA).
Analysis of chromosomal aberrations and anaphase bridges
Cells in exponential growth phase were treated with different concentrations of MNNG (1-5 mM) and post-incubated for 24 h. Cells were arrested at mitosis by the addition of Karyomax colcemid (0.05 mg/ml; Gibco, Carlsbad, CA, USA) for the last 3 h and the metaphase chromosomes were prepared using the standard procedure. Chromosomes were hybridized with telomeric DNA-specific Cy3-labeled peptide nucleic acid probe and the aberrations were scored. For the estimation of anaphase bridges, cells were seeded in two-well chamber slides, treated with MNNG and post-incubated for 24 h. Cells were fixed in acetone:methanol (1:1) and immunostained for 53BP1. Slides were stained with propidium iodide (0.5 mg/ml) and the anaphase bridges were scored in mitotic cells.
Western blot analysis
Primary antibodies were obtained from commercial sources (PARP-1 and cleaved PARP from Cell Signaling Technology (Danvers, MA, USA) and Abcam (Cambridge, MA, USA); PAR from Trevigen; phosphorylated and nonphosphorylated ERK1 and ERK2 from Cell Signaling Technology and actin, a-tubulin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from Santa Cruz Biotechnology (Santa Cruz, CA, USA)). Horseradish peroxidase-conjugated secondary antibodies for anti-mouse and anti-rabbit were procured from Vector Laboratories (Burlingame, CA, USA). Equal amount of proteins (40 mg) isolated from H2AX-proficient and -deficient cells were loaded onto either linear (8%) or gradient (4-12% and 4-20%) polyacrylamide-SDS gels and the proteins were transferred onto polyvinylidene fluoride membranes (Invitrogen). The signal was detected using enhanced Total cellular proteins were isolated at 3 and 24 h after treatment and the PARP activity was determined using a colorimetric assay essentially following the manufacturer's instructions. Biotinylated histone substrate was used to measure PARP activity. PARP activity was determined by measuring the absorbance at 450 nm with a microplate reader (Biotek Synergy 2). The standard curve obtained using purified PARP is shown in the left panel and the PARP activity measured in cells is displayed in the right panel (a). Bars indicate the standard error of the mean of at least three determinations for each treatment condition **Po0.005. (b) PARP-1 expression was determined in H2AX-proficient and -deficient cells at the mRNA and protein levels by reverse transcription (RT)-PCR and western blot analyses. RT-PCR analysis was performed using a standard procedure. PARP-1 expression in sham-and MNNGtreated cells was monitored by western blot using 40 mg of total cellular proteins. Total cellular proteins were isolated 8 and 24 h after MNNG treatment. A nonspecific band detected at B60 kDa was used to verify the equal loading of proteins. PARP-1 expression level observed in all the three cell lines is indicated by asterisks. chemiluminescence (ECL Plus; Amersham, Piscataway, NJ, USA) method following the manufacturer's instructions.
Quantification of PARP activity in whole-cell extracts PARP activity kit (R&D Systems) was used to measure the incorporation of biotinylated PAR into histone proteins. Cellular proteins prepared from sham-and MNNG-treated cells were used for the measurement of PARP activity. First 25 ml of 1 Â PARP cocktail was added to each well. After adding 20 mg protein and corresponding volume of PARP-HSA enzyme to final volume of 50 ml, the plate was incubated at room temperature for 60 min, then washed four times with 1 Â PBS (200 ml per well) and 50 ml of Strep-HRP per well was added. The plate was incubated for 20 min at room temperature and washed four times with 1 Â PBS followed by the addition of 50 ml of TACS-Sapphire to each well. The plate was incubated for 20-30 min in dark and the absorbance was read at 450 nM with a microplate reader. The experiment was performed in triplicates for each treatment condition and postrecovery time.
Analysis of PARP-1 expression by RT-PCR Total cellular RNA was isolated using TRIzol reagent (Invitrogen). Total cellular RNA (1-2 mg) was used for cDNA synthesis following the manufacturer's instructions (Cloned AMV first-strand synthesis kit; Invitrogen). RT-PCR was carried out for PARP-1 detection using the forward and reverse primers (5 0 -GCAGCGAGAGTATTCCCAAG-3 0 ; 5 0 -CCGTCTTCTTGACCTTCTGC-3 0 ). Commercially available primers were used to monitor the expression of GAPDH (Super Array, Frederick, MD, USA).
Statistical analysis
Experimental data were generated from at least three independent determinations for most of the biological end points studied. Statistical significance was estimated by subjecting the data to two-tailed Student's t-test using Microsoft Excel software. For all analyses, data sets obtained for H2AX heterozygous-and homozygous-deficient cells were compared with H2AX-proficient wild-type cells. Statistical significance was accepted at Po0.05. P-value is indicated in the form of asterisks in the figures (*Po0.05; **Po0.005). Figure 7 H2AX is required for the optimal activation of MAPK pathway after alkylation DNA damage. Cells in exponential growth phase were either sham-or N-methyl-N 0 -nitro-N-nitrosoguanidine (MNNG)-treated and the proteins were isolated at 3 and 24 h after treatment. Western blot analysis was performed using antibodies specific for phosphorylated and nonphosphorylated forms of ERK1 and ERK2. Note the impairment in the activation and persistence of phosphorylated forms of ERK1 and ERK2 in H2AX-deficient cells with increasing MNNG concentrations.
